No Mercy / No Malice: Addiction Economy

Economic Shift

GLP1 drugs are reshaping the economic landscape by influencing consumer behavior and spending patterns. George Hahn highlights that these drugs, which help users feel fuller and suppress hunger, have led to a reduction in food and beverage spending by 11% among users. This shift is already impacting sectors like restaurants and grocery stores, with potential GDP growth of over 1% if a significant portion of the obese population adopts GLP1s 1.

GLP1s will likely transform the economy.

--- George Hahn

As these drugs become more prevalent, their broader economic effects will continue to unfold, potentially transforming various industries.

   

Health Dynamics

The health benefits of GLP1 drugs are significant, yet they come with challenges that need addressing. George Hahn notes that while these drugs are the most effective weight loss solutions to date, cost remains a barrier, and only a third of employer health plans cover them for non-diabetic patients 1.

Pharma might just as easily brag billions prescribed after the food industrial complex makes people sick.

--- George Hahn

This highlights the complex interplay between healthcare access and pharmaceutical advancements, underscoring the need for broader coverage and affordability.